SCHEMBL7838696

SCHEMBL7838696

O=P(O)(O)C(CN[C@H]1CC[C@H](O)CC1)P(=O)(O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ANPEP P15144 5/20 0.47
ERAP2 Q6P179 4/20 0.47
EPHX2 P34913 1/20 0.38
KDM4E B2RXH2 1/20 0.35
FDPS P14324 5/20 0.33
MMP2 P08253 1/20 0.32
MMP8 P22894 1/20 0.32
DPP4 P27487 1/20 0.31
HRH1 P35367 1/20 0.31
HRH4 Q9H3N8 1/20 0.31
LMNA P02545 1/20 0.30
GBA1 P04062 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP2D6 P10635 1/20 0.30
CNR1 P21554 1/20 0.30
TBXA2R P21731 1/20 0.30
HRH2 P25021 1/20 0.30
SLC6A4 P31645 1/20 0.30
KCNH2 Q12809 1/20 0.30
HIF1A Q16665 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9315989 0.82 ANPEP (0.68) ANPEPERAP2KDM4EFDPSMMP2
SCHEMBL9564518 0.82 ANPEP (0.68) ANPEPERAP2KDM4EFDPSMMP2
SCHEMBL9316055 0.82 ANPEP (0.68) ANPEPERAP2KDM4EFDPSMMP2
SCHEMBL14279039 0.73 KDM4E (0.41) ANPEPERAP2EPHX2KDM4EHRH1
SCHEMBL18111874 0.73 KDM4E (0.41) ANPEPERAP2EPHX2KDM4EHRH1
SCHEMBL20300042 0.73 KDM4E (0.41) ANPEPERAP2EPHX2KDM4EHRH1
SCHEMBL4813989 0.68 EPHX2 (0.48) EPHX2KDM4EDPP4LMNAGBA1
SCHEMBL4814571 0.68 EPHX2 (0.48) EPHX2KDM4EDPP4LMNAGBA1
SCHEMBL4813992 0.68 EPHX2 (0.48) EPHX2KDM4EDPP4LMNAGBA1
SCHEMBL24349116 0.67 SHBG (0.42) ANPEPERAP2EPHX2KDM4EHRH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6608066-B1 Treating mammal susceptible to, suffering from, suspected of having or recovering from disease impacted by tissue factor, such as cardiovascular, blood coagulation, cell proliferation or immune disorders, atherosclerosis, inflammation or cancer SUNOL MOLECULAR CORPORATION 2003-08-19 US disclosed
US-6608066-B1 Treating mammal susceptible to, suffering from, suspected of having or recovering from disease impacted by tissue factor, such as cardiovascular, blood coagulation, cell proliferation or immune disorders, atherosclerosis, inflammation or cancer SUNOL MOLECULAR CORPORATION 2003-08-19 US disclosed